• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促卵泡激素(FSH)受体基因第10外显子常见单核苷酸多态性对卵巢FSH反应的意义:控制性卵巢过度刺激的药物遗传学方法

Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.

作者信息

Behre Hermann M, Greb Robert R, Mempel Andrea, Sonntag Barbara, Kiesel Ludwig, Kaltwasser Petra, Seliger Ewald, Röpke Friedrich, Gromoll Jörg, Nieschlag Eberhard, Simoni Manuela

机构信息

Andrology Unit, Department of Urology, University Hospital, Halle, University Hospital, Münster, Germany.

出版信息

Pharmacogenet Genomics. 2005 Jul;15(7):451-6. doi: 10.1097/01.fpc.0000167330.92786.5e.

DOI:10.1097/01.fpc.0000167330.92786.5e
PMID:15970792
Abstract

The p.N680S sequence variation of the follicle-stimulating hormone (FSH) receptor gene was previously shown to influence the ovarian response to FSH in normo-ovulatory women undergoing controlled ovarian hyperstimulation. In this prospective, randomized, controlled study, we tested whether the same daily dose of FSH results in lower levels of oestradiol in women homozygous for the p.N680S sequence variation, and whether the difference can be overcome by higher FSH doses. Women undergoing controlled ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection and homozygous for the wild-type or for the p.N680S FSH receptor were randomly assigned to group I (Ser/Ser, n=24), receiving an FSH dose of 150 U/day, or group II (Ser/Ser, n=25), receiving an FSH dose of 225 U/day. In group III (Asn/Asn, n=44), the FSH dose was 150 U/day. Age and basal FSH levels were not different between groups. At ovulation induction, total FSH doses were comparable in group I (1631+/-96 U) and group III (1640+/-57 U) but significantly higher in group II (2421+/-112 U) (P<0.001). Peak oestradiol levels on the day of human chorionic gonadotrophin (hCG) administration were significantly lower in group I (5680+/-675 pmol/l) compared to group III (8679+/-804 pmol/l) (P=0.028). Increasing the FSH dose from 150 to 225 U/day overcame the lower oestradiol response in women with Ser/Ser (group II, 7804+/-983 pmol/l). In women undergoing controlled ovarian hyperstimulation, the p.N680S sequence variation results in lower oestradiol levels following FSH stimulation. This lower FSH receptor sensitivity can be overcome by higher FSH doses.

摘要

促卵泡激素(FSH)受体基因的p.N680S序列变异先前已表明会影响接受控制性卵巢过度刺激的正常排卵女性对FSH的卵巢反应。在这项前瞻性、随机、对照研究中,我们测试了相同每日剂量的FSH是否会使p.N680S序列变异纯合子女性的雌二醇水平更低,以及更高剂量的FSH是否能克服这种差异。接受体外受精或卵胞浆内单精子注射控制性卵巢过度刺激且为野生型或p.N680S FSH受体纯合子的女性被随机分配到I组(Ser/Ser,n = 24),接受150 U/天的FSH剂量,或II组(Ser/Ser,n = 25),接受225 U/天的FSH剂量。III组(Asn/Asn,n = 44)的FSH剂量为150 U/天。各组之间年龄和基础FSH水平无差异。在排卵诱导时,I组(1631±96 U)和III组(1640±57 U)的总FSH剂量相当,但II组(2421±112 U)显著更高(P<0.001)。与III组(8679±804 pmol/l)相比,I组在人绒毛膜促性腺激素(hCG)给药当天的雌二醇峰值水平显著更低(5680±675 pmol/l)(P = 0.028)。将FSH剂量从150 U/天增加到225 U/天可克服Ser/Ser女性(II组,7804±98 pmol/l)较低的雌二醇反应。在接受控制性卵巢过度刺激的女性中,p.N680S序列变异导致FSH刺激后雌二醇水平更低。这种较低的FSH受体敏感性可通过更高剂量的FSH克服。

相似文献

1
Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.促卵泡激素(FSH)受体基因第10外显子常见单核苷酸多态性对卵巢FSH反应的意义:控制性卵巢过度刺激的药物遗传学方法
Pharmacogenet Genomics. 2005 Jul;15(7):451-6. doi: 10.1097/01.fpc.0000167330.92786.5e.
2
Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.控制性卵巢过度刺激的药物遗传学:验证 FSH 受体遗传标志物临床实用性的时候到了。
Pharmacogenomics. 2010 Nov;11(11):1613-8. doi: 10.2217/pgs.10.156.
3
The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.促卵泡激素受体基因中的Ser680Asn多态性与控制性卵巢过度刺激中的卵巢反应相关。
Clin Endocrinol (Oxf). 2015 Apr;82(4):577-83. doi: 10.1111/cen.12573. Epub 2014 Oct 3.
4
Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study.根据促卵泡激素(FSH)受体多态性p.N680S,用人重组FSH治疗可改善特发性不育男性的精子DNA片段化:一项药物遗传学研究。
Hum Reprod. 2016 Sep;31(9):1960-9. doi: 10.1093/humrep/dew167. Epub 2016 Jun 20.
5
Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).使用尿促性素(Metrodin)或重组促卵泡生成素(Puregon)进行控制性卵巢过度刺激后的雌二醇和免疫反应性抑制素样分泌模式。
Hum Reprod. 1996 May;11(5):962-7. doi: 10.1093/oxfordjournals.humrep.a019332.
6
Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET.促卵泡生成素受体基因多态性与体外受精-胚胎移植中卵巢对控制性卵巢过度刺激的反应
J Hum Genet. 2006;51(8):665-670. doi: 10.1007/s10038-006-0005-5. Epub 2006 Jul 27.
7
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.Corifollitropin Alfa 与重组 FSH 在 IVF 卵巢刺激中药代动力学和卵泡动力学比较。
Reprod Biomed Online. 2010 Nov;21(5):593-601. doi: 10.1016/j.rbmo.2010.06.032. Epub 2010 Jun 30.
8
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.卵巢对促卵泡激素(FSH)刺激的反应取决于FSH受体基因型。
J Clin Endocrinol Metab. 2000 Sep;85(9):3365-9. doi: 10.1210/jcem.85.9.6789.
9
In Estimated Good Prognosis Patients Could Unexpected "Hyporesponse" to Controlled Ovarian Stimulation be Related to Genetic Polymorphisms of FSH Receptor?在估计预后良好的患者中,对控制性卵巢刺激的意外“低反应”是否与促卵泡激素受体的基因多态性有关?
Reprod Sci. 2016 Aug;23(8):1103-8. doi: 10.1177/1933719116630419. Epub 2016 Feb 22.
10
Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.单剂量长效重组促卵泡激素(FSH-CTP,注射用重组人促卵泡激素α)诱导多个卵泡发育用于体外受精前的控制性卵巢刺激。
J Clin Endocrinol Metab. 2004 May;89(5):2062-70. doi: 10.1210/jc.2003-031766.

引用本文的文献

1
Impact of gonadotropin genetic profile and ovarian reserve on controlled ovarian stimulation: data from prospective cohort of the GENOCS trial.促性腺激素基因谱和卵巢储备对控制性卵巢刺激的影响:来自GENOCS试验前瞻性队列的数据。
Front Endocrinol (Lausanne). 2025 Aug 22;16:1601803. doi: 10.3389/fendo.2025.1601803. eCollection 2025.
2
Role of follicle-stimulating hormone receptor polymorphism in predicting ovarian response to letrozole in women with polycystic ovary syndrome during ovulation induction.促卵泡生成素受体多态性在预测多囊卵巢综合征女性排卵诱导期间对来曲唑的卵巢反应中的作用。
Front Endocrinol (Lausanne). 2025 Jun 19;16:1585655. doi: 10.3389/fendo.2025.1585655. eCollection 2025.
3
Pharmacogenetic analysis using artificial intelligence (AI) to identify polymorphisms associated with sub-optimal ovarian response and hyper-response.
利用人工智能进行药物遗传学分析,以识别与卵巢反应欠佳和过度反应相关的多态性。
J Assist Reprod Genet. 2025 Apr 2. doi: 10.1007/s10815-025-03471-z.
4
FSH/LH co-stimulation in Advanced Maternal Age (AMA) and hypo-responder patients - Arabian gulf delphi consensus group.高龄产妇(AMA)和低反应患者中的促卵泡生成素/促黄体生成素联合刺激——阿拉伯湾德尔菲共识小组
Front Endocrinol (Lausanne). 2024 Dec 12;15:1506332. doi: 10.3389/fendo.2024.1506332. eCollection 2024.
5
An update review of the application of single-cell RNA sequencing in pregnancy-related diseases.单细胞RNA测序在妊娠相关疾病中的应用最新综述
Front Endocrinol (Lausanne). 2024 Dec 9;15:1415173. doi: 10.3389/fendo.2024.1415173. eCollection 2024.
6
Effect of follicle-stimulating hormone dose on the risk of being classified as suboptimal responders according to the POSEIDON criteria.根据POSEIDON标准,促卵泡激素剂量对被归类为次优反应者风险的影响。
J Assist Reprod Genet. 2024 Dec;41(12):3387-3398. doi: 10.1007/s10815-024-03296-2. Epub 2024 Oct 18.
7
Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria.ART 预后不良患者:德尔菲共识以确定潜在的临床意义并衡量 POSEIDON 标准的影响。
Reprod Biol Endocrinol. 2024 Oct 10;22(1):122. doi: 10.1186/s12958-024-01291-x.
8
The Additive Effect of Combinations of FSH Receptor Gene Variants in Ovarian Response to Stimulation.FSH 受体基因变异组合对刺激卵巢反应的累加效应。
Reprod Sci. 2024 Nov;31(11):3560-3568. doi: 10.1007/s43032-024-01700-x. Epub 2024 Sep 25.
9
Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus.控制性卵巢刺激中促黄体生成素补充治疗:伊朗德尔菲共识
Front Reprod Health. 2024 May 9;6:1397446. doi: 10.3389/frph.2024.1397446. eCollection 2024.
10
Genetic Variants of Gonadotropins and Their Receptors Could Influence Controlled Ovarian Stimulation: IVF Data from a Prospective Multicenter Study.促性腺激素及其受体的遗传变异可能影响控制性卵巢刺激:一项前瞻性多中心研究的 IVF 数据。
Genes (Basel). 2023 Jun 15;14(6):1269. doi: 10.3390/genes14061269.